Updated: Dec 8, 2020
CareSart COVID-19 Ag
FDA (U.S Food & Drug Administration) Emergency Use Authorization
Type: Antigen COVID-19 Diagnostic kits
Result: within 10 mins
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Lateral flow assay
Rapid results in 10 minutes
Minimally invasive specimen collection (nasopharyngeal)
Intended at POC setting (i.e., in patient care settings) by medical professionals
Detect SARS-CoV-2 nucleocapsid protein antigen
Identify acute infection with high sensitivity and 100% specificity
Purchasing or more information
We are the authorized dealer for the Access Bio's COVID-19 Test kits.
Fact Sheet For Healthcare Providers
Fact Sheet For Patients
IFU (Instructions for use)
FDA EMERGENCY USE AUTHORIZATION
ACCESS BIO ANTIGEN PROFILE